Psychiatric medication‐induced obesity: treatment options
- 30 September 2004
- journal article
- review article
- Published by Wiley in Obesity Reviews
- Vol. 5 (4) , 233-238
- https://doi.org/10.1111/j.1467-789x.2004.00149.x
Abstract
A majority of psychiatric medications are known to generate weight gain and ultimately obesity in some patients. The authors undertook a comprehensive literature review in order to provide a better understanding of novel treatment options in regards to alleviating weight gained by use of antidepressants, antipsychotics, and mood stabilizers. There are no agents for management of this weight gain approved by the Food and Drug Administration (FDA), and existing studies on options are mainly uncontrolled, small-scale projects with limited power to produce coherent conclusions. There is a clear need for larger studies on existing options, and future psychotropics without these side-effects are currently in the pipeline.Keywords
This publication has 47 references indexed in Scilit:
- Bodyweight Gain Associated with Atypical AntipsychoticsCNS Drugs, 2001
- Weight gain associated with psychotropic drugsExpert Opinion on Pharmacotherapy, 2000
- Body-Mass Index and Mortality in a Prospective Cohort of U.S. AdultsNew England Journal of Medicine, 1999
- OrlistatDrugs, 1998
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- The Effect of Orlistat, an Inhibitor of Dietary Fat Absorption, on the Absorption of Vitamins A and E in Healthy VolunteersThe Journal of Clinical Pharmacology, 1996
- A Double‐Blind Randomized Placebo‐Controlled Trial of SibutramineObesity Research, 1996
- Bodyweight Change as an Adverse Effect of Drug TreatmentDrug Safety, 1996
- The Effect of Orlistat, an Inhibitor of Dietary Fat Absorption, on the Pharmacokinetics of β‐Carotene in Healthy VolunteersThe Journal of Clinical Pharmacology, 1996